Friday, November 22, 2024
HomeTagsProduct IBI345

product IBI345

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics